Κατάλογος ενδεικτικών δημοσιεύσεων του τμήματος Ιατρικής ΑΠΘ σε διεθνή επιστημονικά περιοδικά κατά τα τελευταία 5 έτη.
Export 34 results:
Συντάκτης Τίτλος Τύπος [ Έτος] Φίλτρα: Keyword is Parathyroid Hormone [Clear All Filters]
New therapeutic targets for osteoporosis..
Maturitas. 120, 1-6.
(2019). OPG/RANK/RANKL signaling axis in patients with type I diabetes: Associations with parathormone and vitamin D..
Ital J Pediatr. 45(1), 161.
(2019).
(2019). Acetylcholinesterase activity and bone biochemical markers in premature and full-term neonates..
J Pediatr Endocrinol Metab. 31(12), 1363-1366.
(2018).
(2018).
(2018). The intriguing connections of leptin to hyperparathyroidism..
Endocrine. 57(3), 376-387.
(2017). Defining optimal vitamin D cut-off levels: Τhe role of parathyroid hormone concentrations..
Hormones (Athens). 15(4), 565-567.
(2016). Circulating semaphorin-4D and plexin-B1 levels in postmenopausal women with low bone mass: the 3-month effect of zoledronic acid, denosumab or teriparatide treatment..
Expert Opin Ther Targets. 19(3), 299-306.
(2015). Investigational parathyroid hormone receptor analogs for the treatment of osteoporosis..
Expert Opin Investig Drugs. 24(2), 145-57.
(2015). Circulating irisin is associated with osteoporotic fractures in postmenopausal women with low bone mass but is not affected by either teriparatide or denosumab treatment for 3 months..
Osteoporos Int. 25(5), 1633-42.
(2014). Circulating periostin levels do not differ between postmenopausal women with normal and low bone mass and are not affected by zoledronic acid treatment..
Horm Metab Res. 46(2), 145-9.
(2014). The effect of leptin replacement on parathyroid hormone, RANKL-osteoprotegerin axis, and Wnt inhibitors in young women with hypothalamic amenorrhea..
J Clin Endocrinol Metab. 99(11), E2252-8.
(2014). Patterns in the parathyroid response to sodium bicarbonate infusion test in healthy volunteers..
Biomed Res Int. 2014, 704394.
(2014). A rare case of a parathyroid adenoma inside a parathyroid cyst..
Arq Bras Endocrinol Metabol. 58(7), 776-8.
(2014). COSMOS: the dialysis scenario of CKD-MBD in Europe..
Nephrol Dial Transplant. 28(7), 1922-35.
(2013). Parathyroid hormone changes following denosumab treatment in postmenopausal osteoporosis..
Clin Endocrinol (Oxf). 79(4), 499-503.
(2013). Plasma serotonin and markers of bone formation and bone resorption in hemodialysis patients..
Iran J Kidney Dis. 7(1), 36-41.
(2013). Serum osteoprotegerin is markedly increased and may contribute to decreased blood T cell count in hemodialysis patients..
Int Urol Nephrol. 45(6), 1671-7.
(2013). Serum sclerostin levels following treatment with parathyroid hormone..
J Endocrinol Invest. 36(4), 280.
(2013). De novo autoimmune hepatitis associated with PTH(1-34) and PTH(1-84) administration for severe osteoporosis in a liver transplant patient..
Osteoporos Int. 23(9), 2387-91.
(2012). Diagnostic and therapeutic review of cystic parathyroid lesions..
Hormones (Athens). 11(4), 410-8.
(2012). Inverse association of serum 25-hydroxyvitamin D with markers of inflammation and suppression of osteoclastic activity in hemodialysis patients..
Iran J Kidney Dis. 6(2), 129-35.
(2012). Prevalence and predictors of the sub-target Hb level in children on dialysis..
Nephrol Dial Transplant. 27(10), 3950-7.
(2012). Secretory capacity of the parathyroid glands after total thyroidectomy in normocalcemic subjects..
J Clin Endocrinol Metab. 97(7), 2341-6.
(2012).